Lorna Nicholas
Lorna has more than 15 years' experience as a business/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.
ACDC Metals completes drilling at Goschen Central, moves rig to Watchem project
ACDC Metals (ASX: ADC) is a step closer to releasing a JORC resource after completing drilling program at its Goschen Central heavy mineral sand and rare earth element (REE) project in Victoria’s Murray Basin. In this latest campaign, 77 holes for 4,038m were undertaken in February at Goschen Central, and samples have been despatched for […]
Akora’s pending mining permits continue processing after Madagascar’s EITI upgrade
Processing of Akora Resources’ (ASX: AKO) pending iron ore mining permits in Madagascar will continue as part of the legal upgrade of the country’s Extractive Industries Transparency Initiative (EITI). More than 50 countries across the world have committed to strengthening the transparency and accountability of their mining and processing sectors using the EITI standard. Madagascar […]
Neurotech International completes recruitment for PANDAS/PANS clinical trial
Neurotech International (ASX: NTI) has completed recruitment for a phase I/II trial assessing its lead candidate NTI164 in children with paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and paediatric acute-onset neuropsychiatric syndrome (PANS). All-up, 15 paediatric patients with PANDAS/PANS have begun treatment with NTI164, which is a cannabinoid-based drug derived from a unique […]
Imugene presents abstract on ‘impressive’ pre-clinical liver cancer treatment response
Imugene (ASX: IMU) has unveiled “impressive” pre-clinical in vivo anti-tumour responses using its onCARlytics technology in combination with Eureka Therapeutics’ Artemis’ T cell platform on models with liver cancer. The company presented an abstract titled ‘Effective combination immunotherapy using onCARlytics and Artemis CD19 T cells against hepatocellular carcinoma’ at the American Society of Gene and […]
IGO to farm-into Venus Metals’ Henderson nickel and lithium project
Major miner IGO (ASX: IGO) has agreed to farm-into Venus Metals’ (ASX: VMC) Henderson nickel-lithium project in Western Australia, with the deal including a $1 million “reimbursement” to the junior. Under the deal announced this morning, IGO can progressively acquire up to 70% of the project by spending $4 million on exploration and providing a […]
Revolver Resources raises $5m to accelerate exploration at copper projects
Revolver Resources (ASX: RRR) has raised $5 million to accelerate exploration across its Osprey and Dianne copper projects in Queensland. The company received firm commitments to raise $5 million via a placement and convertible loan facility to institutional and sophisticated investors. Under the placement, Revolver has secured binding commitments to generate $2 million through the […]
Power Minerals attracts $2.6m strategic investment from Fuyang Mingjin
Power Minerals (ASX: PNN) has attracted the attention of industry investor Fuyang Mingjin New Energy Development, which will scoop up $2.6 million shares to secure a strategic holding. Under an agreed placement, Fuyang will subscribe for 6.5 million Power shares at $0.40 each – giving it an 8.9% interest. Fuyang’s strategic $2.6 million investment will […]
Latest resource update to Galan’s HMW project shows ‘enormity’ of lithium brine potential
Galan Lithium (ASX: GLN) has debuted an updated resource for its Hombre Muerto West (HMW) lithium brine project in Argentina, which managing director Juan Pablo Vargas de la Vega says highlights the “enormity” of its potential. Total resources at HMW have increased to 6.6 million tonnes of contained lithium carbonate equivalent grading 880 milligrams per […]
Site Group International raising $4m to fund its growth strategies
Site Group (ASX: SIT) is on-track to secure the capital required to pursue its growth strategies, with a raising underway attracting “outstanding support” and the company approving a shortfall placement and an increase to the $3.9 million target. As part of the previously announced entitlement offer, Site retained the right to place any shortfall of […]
Blackmores greenlights $1.8b Kirin takeover, Kogan remains profitable as sales soften and Megaport reveals higher EBITDA guidance
Shares in Australia’s largest health supplement group Blackmores (ASX: BKL) surged this week after it revealed Japan’s Kirin had made a $1.8 billion offer. Blackmore’s board and major shareholder Marcus Blackmore have given the acquisition the green-light. Mr Blackmore had an 18% stake in the company his father founded, and sold his holding to Kirin […]
Avecho Biotechnology poised to begin ‘pivotal’ clinical study of proprietary CBD drug in treating insomnia
Avecho Biotechnology (ASX: AVE) is poised to begin “pivotal” phase III clinical studies evaluating its proprietary cannabidiol (CBD) soft gel capsule in treating insomnia. During the March quarter (Q3 FY2023), Avecho continued development of its products that have been designed with its proprietary Tocopheryl Phosphate Mixture (TPM) drug delivery system. The company’s TPM drug delivery […]
Neurotech International progresses plans for NTI164 trial in Rett syndrome
Clinical stage biopharmaceutical company Neurotech International’s (ASX: NTI) plans for a phase II trial evaluating its NTI164 candidate in children with Rett syndrome are progressing, with final regulatory approvals expected in the current quarter. The company launched the clinical program in late March and its plans to investigate NTI164, which is a cannabinoid-based drug in […]
Tambourah Metals gears-up for busy quarter advancing critical mineral and gold projects
Tambourah Metals (ASX: TMB) is gearing-up for a busy June quarter as it rapidly advances its critical mineral and gold projects in Western Australia. To drive the accelerated exploration program, Tambourah appointed Ralf Kriege as its chief executive officer in March and he officially began the role this month. Tambourah chair Rita Brooks said Mr […]
Frontier Energy progresses funding and offtake discussions for Bristol Springs
Frontier Energy (ASX: FHE) has progressed funding and offtake discussions after a definitive feasibility study confirmed its Bristol Springs renewable energy project in Western Australia as a “low cost”, “early mover” in green hydrogen development. The company is proposing to build Bristol Springs about 120km south of Perth. The project will involve establishing solar energy […]
Vintage Energy celebrates watershed March quarter with maiden production from Vali gas field
Vintage Energy (ASX: VEN) heralded a “milestone” March quarter (Q3 FY2023), which saw it transition from gas explorer to producer at its Vali field in the Cooper Basin. Gas production from the Vali-1 well came online in February, with the Vali-3 well operational by the end of the quarter. During the period, 0.48 petajoules equivalent […]
International Graphite’s battery anode material facility could generate ‘outstanding financial returns’
A scoping study has confirmed International Graphite’s (ASX: IG6) proposed Collie graphite battery anode material facility could generate “outstanding financial returns”. The study estimates the Collie facility could produce up to 40,000 tonnes a year of graphite concentrates. Using a flowsheet involving graphite micronising, spheroidising and non-HF chemical purification, International Graphite will produce an uncoated […]
Ioneer boosts South Basin lithium carbonate resource by 168% at Rhyolite Ridge
As it progresses towards development, Ioneer (ASX: INR) has revealed a 168% increase to contained lithium carbonate resources for the South Basin deposit within its Rhyolite Ridge project in Nevada in the US. The updated resource now totals 3.4 million tonnes of lithium carbonate equivalent – up from 1.2Mt in the previous estimate. Contained boric […]
Vintage Energy, Metgasco and Bridgeport report ‘pleasing’ production at Vali-1 gas well
Vintage Energy (ASX: VEN) and joint venture partners Metgasco (ASX: MEL) and Bridgeport have reported “pleasing progress” from the producing Vali-1 well within the Cooper Basin. The well has continued to perform “in-line” with pre-production forecasts and test results – maintaining consistent production and high availability throughout its 65 days online through to 26 April. […]
Imugene lifts bank balance with $12.6m rebate to progress immune-oncology therapies
Imugene (ASX: IMU) has more cash in the bank to pursue ongoing development of its immuno-oncology therapies following a $12.6 million research and development tax refund from the Australian Government. Under the government’s research and development tax incentive scheme, companies engaging in eligible activities can receive a refundable tax offset of up to 43.5%. Imugene […]
Chimeric Therapeutics receives ethics approval for phase 1B study in patients with brain cancer
Chimeric Therapeutics (ASX: CHM) has received ethics approval for a phase 1B clinical trial evaluating its CHM 1101 candidate in patients with recurrent or progressive brain cancer. CHM 1101 is a novel chimeric antigen receptor technology (CAR-T) therapy that has been designed to target solid tumours. The therapy uses a 36-amino peptide that has been […]